![](/img/cover-not-exists.png)
A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first-line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial
Hagman, H., Frödin, J.-E., Berglund, Å., Sundberg, J., Vestermark, L. W., Albertsson, M., Fernebro, E., Johnsson, A.Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv490
Date:
October, 2015
File:
PDF, 230 KB
english, 2015